QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of product and partnership updates designed ...

Genomic Medicine Market Growth is Driven by NGS Adoption, Government Initiatives, and Pharma Investment in Targeted Genomic Therapies.Austin, April 22, 2025 (GLOBE NEWSWIRE) -- Genomic Medicin Market ...

A review evaluated the distribution and predictive capabilities of three genomic assays for breast cancer across different ...

The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

Fortis stated that the application of genomic science will aid in early diagnosis and personalised treatment across fields such as oncology, cardiology, and neurology. In oncology, genomic testing ...

The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...

Backed by Fortis' advanced clinical ecosystem and Agilus Diagnostics' extensive national footprint, the institute will bring together a multidisciplinary team of medical experts, including Molecular ...

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

More information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Targeted small molecule ...

At the heart of this collaboration is Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS. A globally recognized expert in precision oncology and drug development ...